---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-063185"
form_type: "8-K"
ticker: "SILO"
cik: "0001514183"
company_name: "Silo Pharma, Inc."
filed_at: "2026-06-01T13:02:13+00:00"
generated_at: "2026-06-01T13:08:21.817335+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# Silo Pharma announces 1-for-15 reverse stock split effective June 2, 2026

## Summary
- 1-for-15 reverse split effective 4:01 pm ET on June 2, 2026; post-split trading begins June 3 under same symbol SILO.
- Outstanding shares reduced from ~16.267M to ~1.084M; authorized shares cut proportionately to 6,666,667.
- CUSIP changes to 82711P 300; fractional shares rounded up to the next whole share.
- Equitable adjustments made to equity awards and warrants, including exercise prices.

## SEC filing metadata
- accession: 0001213900-26-063185
- form_type: 8-K
- ticker: SILO
- cik: 0001514183
- company_name: Silo Pharma, Inc.
- filed_at: 2026-06-01T13:02:13+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1514183/000121390026063185/0001213900-26-063185-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1514183/000121390026063185/ea0292702-8k_silo.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-063185
- JSON: https://secwatch.observer/filing/0001213900-26-063185.json
- Plain text: https://secwatch.observer/filing/0001213900-26-063185.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.